Home-Based PrEP for Youth

1155
Home-Based PrEP for Youth
United States of America
To evaluate a model of oral HIV pre-exposure prophylaxis (PrEP) implementation for youth that includes home PrEP (with fewer in-person clinic visits and a telemedicine approach). The objective is to evaluate the safety, acceptability of and adherence to home-based daily oral PrEP among young men who have sex with men and transgender women.
Hide Title
Off
Hide Teaser
Off
Hide Partners
Off
Hide Program Location
Off
Hide Program Initiative
Off
Hide Program Type
Off
Hide Tags
Off

World AIDS Day—New Strategy Aims to Take on Cryptococcal Meningitis, Which Threatens Those With HIV

Read more

CDC’s Faces from the Frontlines featured at Atlanta Airport

Read more

Eliminating HIV in The United States

Read more

Development of Antiretroviral Rings for HIV Prevention

989
Image
infectious disease
Development of Antiretroviral Rings for HIV Prevention
United States of America
To evaluate a topical HIV prevention product using a nonhuman primate, repeat low dose model to define activity and toxicity of an intravaginal ring product.

Hide Title
Off
Hide Teaser
Off
Hide Partners
Off
Hide Program Location
Off
Hide Program Initiative
Off
Hide Program Type
Off
Hide Tags
Off

Walgreens Donates Funds to Support the CDC Foundation’s Sustainable Healthcenter Implementation PrEP Pilot

Following last year’s impactful collaboration between Walgreens and the CDC Foundation addressing the Zika outbreak, the two organizations are once again working together to help address another public health challenge—HIV prevention. To help extend the CDC Foundation’s important research and demonstration project, Walgreens made a donation today to help fund the CDC Foundation’s Sustainable Healthcenter Implementation PrEP Pilot (SHIPP) study.

Global Cryptococcal Meningitis Screening

950
Image
global health
Global Cryptococcal Meningitis Screening
Botswana
Lesotho
Malawi
Mozambique
Nigeria
Senegal
Tanzania
Uganda
South Africa
To determine feasibility and cost of prevention of Cryptococcal disease in African, Asian and Central American countries via the implementation of a “screen-and-treat” strategy. This strategy will support and guide policy makers in the rollout and sustained management of a successful “screen-and-treat” program. This project is expanding to an additional 8-12 countries.
Pfizer Inc.
CDC's National Center for Emerging and Zoonotic Infectious Diseases
Subscribe to HIV